yr Ba3/BB +

Related by string. * y r . Yrs . YRS . yrs . YR . YRD . yrd . YRs . Yr : Latest Yr ago . 5 ,# yr . 5 YR YTD . yr olds . yr CITI . #-#/# yr . pct yr yr . yr A1 / : yr Ba3/BB- . yr Ba3/BB . yr Ba3/BB- CSFB / + - [008] . + - [003] . + - [027] . + - [020] . + - [007] . + - [017] . + - [022] . + - [001] : + S europe . Average + -1 . Crispin Porter + Bogusky . + input switcher . diagnosed Ph + . assigned BBB + . Ph + CML . Ph + ALL * *

Related by context. All words. (Click for frequent words.) 72 yr B3/B- 72 yr B1 B 71 yr A2/A- 69 yr NA NA 69 yr -/- 68 yr JPM 68 yr frn 68 yr CITI 67 yr Baa2/BBB/NA 67 yr Ba1/BBB- 67 yr Caa1/CCC + 67 8 yr B3/B- 67 yr Ba3/BB- 67 yr B2 B 66 yr B2/B- 66 yr BAML 66 yr Baa2/BBB/BBB 65 -prefixing 65 yr -/- DBS 65 yr Ba2/BB + 64 yr Baa2/BBB + 64 yr A2/A/A + 64 yr Ba2/BB 64 CITI BAS 64 yr BAML JPM 64 CITI DB 64 yr Baa3/BBB-/BBB- 64 yr Baa3/BBB 64 LEH ML 64 yr Baa1/BBB + 63 yr BAS 63 -ground truthing 63 yr Baa2/BBB 63 yr BARC 63 yr A2/A/NA 63 yr Ba3 B 63 CITI JPM 63 yr A3/BBB + 63 yr A3/A- 63 NA JPM 63 yr Aa2/AA- 62 yr A2/A/A 62 DB JPM 62 yr Baa3/BBB + 62 yr Baa3/BBB- 62 yr A2/BBB + 62 yr Baa3/BBB-/NA 62 3 yr frn 62 yr B3/B-/NA 62 yr CITI JPM 62 JPM LEH 62 -Accused rapist 62 BAS JPM 62 BOND SALES COMPANY Amt 61 GS ML 61 yr CITI GS 61 yr Aa2 61 NA BAS 61 yr A3 61 -Sukhvinder 61 5 yr Aa3/AA 61 yr GS JPM 61 yr Ba1/BB + 61 -Director Robert Schwentke 61 yr Aa3 61 yr A3/A-/A- 61 CITI GS 61 CSFB DBS 61 Debt Rtgs Mgrs Priced 60 yr Baa2/BBB- 60 -Fantasticat 60 yr B3 B 60 GS LEH 60 yr CITI DB 60 -David Gibbon Gaming 60 LEH MS 60 yr Baa1/A- 60 CSFB JPM 60 BAS GS 60 BARC JPM 60 MS WFS 60 CITI CS 60 Completes Purchase Of 60 yr Baa1/BBB 60 yr -/- MS 60 SALES COMPANY Amt Mat 59 yr Baa1/A-/A- 59 yr Baa2/BBB CITI JPM 59 RBSGC 59 yr B3/B- JPM 59 yr Aa2/AA + 59 SALES EXPECTED FOR 59 COMPANY Amt Mat Debt 59 -visit www.forrester.com 59 GS JPM 59 NA BAML 59 CITI ML 59 Services #:#-#,# Abstract 59 GS SSB 59 yr A1 59 yr mtn 58 yr Baa3/BB + 58 yr Aaa AAA 58 JPM MS 58 8 yr B2/B- 58 yr Aa2/AA 58 Settles Dispute With 58 Immunol 58 yr BAS DB 58 BOND SALES COMPANY AMT 58 SALES COMPANY AMT MAT 58 + NA BARC 58 Completes Merger With 58 yr Baa2/BBB CITI GS 58 PRICED * 58 Backs FY# Outlook 57 Resumes Coverage 57 Radiol 57 BAML JPM 57 yr Aa3/AA- 57 Declines Quick Facts 57 yr A3/A-/NA 57 BAML CITI 57 BARC CITI 57 Closes Acquisition Of 57 Rises Quick Facts 57 BAS CITI 57 JPM BAS 57 BOND SALES 57 yr Ba3/BB- CSFB 57 Mat Debt Rtgs Mgrs 57 MS CITI 57 yr A2 57 BAS BOCM 57 JPM CITI 57 yr Aa1/AA- CITI 57 J Clin 57 CITI MS 56 -grassless 56 JPM WACH 56 Maintains Buy Rating 56 yr Baa3/BBB- CITI 56 yr FRN 56 #/#/# COMPANY AMT [001] 56 Announce Expiration 56 Fitch Ratings Affirms 56 yr Baa2/BBB ML 56 Endocrinol 56 BAML CS 56 NA BARC 55 Radiat 55 MAT DEBT RTGS MGRS 55 Curr Opin 55 EPT Disclosure 55 Servs 55 Pathol 55 Sweetens Bid 55 JPM ML 55 Alert Trend Down 55 Announces Job Cuts 55 Q1 Profit Surges 55 Lowers Estimates 55 BARC DB 55 BARC BNP 55 Lifts FY# Outlook 55 yr -/- GS 55 Paid Lobbyist 55 Reiterates Buy Rating 55 EXPECTED FOR WEEK 54 -FINAL FANTASY CRYSTAL CHRONICLES 54 CITI DBS 54 CSFB CITI 54 Rtgs Mgrs Date Postponed 54 Withdraws Proposal 54 Intnl 54 Shareholders Approve Acquisition 54 Hld 54 PROFILE CO 54 + NA CITI 54 Child Adolesc Psychiatry 54 Ups Stake 54 Raises Stake 54 Int J 54 BAS BARC 54 Raises PT 54 1Q Profit Up 54 Eur J 54 Free Full Text 54 yr frn Aaa AAA 54 Moving Average Crossover Alert 54 AMT MAT DEBT RTGS 54 Analysts Begin Coverage 54 Lowers Price 54 BAS CSFB 54 Cramer Take Stockpickr downgraded 54 Persbericht 54 Boosts Estimates 54 Ups Bid 54 yr Ba2/BBB- BAS CSFB 54 Reaffirms FY# Outlook 54 Withdraws Offer 54 + NA BAML 54 Raises Bid 54 Neurol 54 Q2 Profit Surges 54 Rtgs Mgrs Priced 54 earns rev 54 Publ 54 Q1 Profit Decreases 54 IDR affirmed 54 LEH JPM 54 DGAP Ad hoc 54 Q3 Adj 53 Completes Redemption 53 yr frn Aa3 53 J Appl 53 Stays Neutral 53 Q2 Adj 53 CS JPM 53 CSFB ML 53 Fitch Ratings Downgrades 53 Assocs 53 CITI LEH 53 UBS Downgrades 53 NewsBite Downgrade Puts Pressure 53 #/Aug 53 Finalizes Purchase Of 53 Calls Purchased 53 Q1 Profit Rises 53 Q3 Profit Surges 53 Q3 Profit Plunges 53 DEBT RTGS MGRS PRICED 53 #.#-#.# mln vs. [002] 53 Fitch Assigns Ratings 53 Affirms FY# 53 Pract 53 Q4 Profit Surges 53 Cuts Stake 53 Fncl 53 Backs FY# EPS 53 Concludes Acquisition 53 Reiterates Buy 53 Q1 Profit Soars 53 Q1 Profit Plunges 53 CITI CSFB 53 Resp 53 Q2 Profit Plunges 53 Glb 53 yr Aa3/AA 53 Cuts FY# EPS 53 Increases Stake 53 Bearish Speculation 53 FY# Profit Declines 53 Completes Tender Offer 53 Singapore Bourse Change 53 PRICED 53 Trims Loss 53 Rating Maintained 53 Q4 Profit Plunges 53 CEO Exercises Options 53 SWOT Analysis Aarkstore Enterprise 53 Lifts Dividend 53 FY# Profit Surges 52 alt Sec 52 CORRECTED CORRECTED UPDATE 52 + NA BAS 52 Acquires Majority Stake 52 Remains Neutral 52 Acquires Assets 52 Am J Geriatr 52 Second Quarter Profit Rises 52 Net Pft Seen 52 Puts Purchased 52 Ophthalmol 52 Pharmacother 52 Q4 Profit Soars 52 Q2 Profit Soars 52 Completes Sale Of 52 Fourth Quarter Profit Rises 52 Posts 2Q Loss 52 Posts 4Q 52 Grp Hldgs 52 Br J 52 CrossRef Medline 52 Q3 Profit Soars 52 Lifts FY# Guidance 52 NUMBERS GENERAL HIGH YIELD 52 Q3 Profit Drops 52 Abstract Full Text 52 Posts Wider Loss 52 Q2 Profit Declines 52 Q2 Profit Rises 52 #:#-#,# [002] 52 FY# Profit Rises 52 J Biol 52 Geriatr 52 For Undisclosed Terms 52 4Q Profit Up 52 Buys Controlling Stake 52 Oncol 52 Bearish Technical 52 Buys Majority Stake 52 Increases Quarterly Cash Dividend 52 4Q Net MYR#.#M [001] 52 Q2 Profit Slips 52 Wins Dismissal 52 Orthop Surg 52 Q2 Profit Drops 52 Revises FY# EPS 52 Net Profit Jumps 52 Finalizes Sale 52 Welcomes Analyst Initiation 52 Q4 Loss Narrows 52 Results Disappoint 52 Q1 Adj 52 Acquires Stake 52 Lifts FY# EPS 52 Bnd 52 4Q Net Pft 52 Cal. App 52 Q3 Loss Narrows 52 Stock Downgraded 52 Lifts FY# Earnings 52 Q3 Profit Plummets 52 Q3 Loss Widens 52 4th Qtr Profit Rises 52 FY# Q3 earnings 52 Q1 Profit Declines 52 J Consult Clin 51 Profit Increases 51 Gets Bearish Confirmation 51 Svcs 51 Q2 Profit Climbs 51 Orthop 51 CORRECTED CORRECTED OFFICIAL 51 Suppl 51 Settle Litigation 51 Scand J 51 #:#-#,# Medline 51 ots.CorporateNews 51 CORRECTED OFFICIAL UPDATE 51 Crit Rev 51 Bullish Average Crossover 51 2Q Net Pft 51 Finalizes Sale Of 51 Barclays Maintains 51 BOCM JPM 51 OFFICIAL CORRECTION 51 Commences Tender Offer 51 Exec Joins 51 Neurosurg 51 Bnk 51 Beats Estimates Analyst Blog 51 Bearish Average Crossover 51 Cuts FY# 51 Narrows Guidance 51 Net Pft 51 2Q Profit Rises 51 Planned Acquisition 51 Q1 Loss Narrows 51 3Q Profit Jumps 51 Q3 Profit Rises 51 3Q Profit Up 51 Bullish Engulfing Pattern 51 #/#/# COMPANY AMT [002] 51 BAS DB 51 Reaffirms FY# EPS 51 pro Aktie 51 Neurosci 51 Announces Early Termination 51 reaffirms FY# outlook 51 Q4 Profit Drops 51 Plans Buyback 51 BAS JPM MS 51 Sells Stake 51 Abstract Free Full Text 51 2Q Profit Climbs 51 Lazard Hires 51 Rheumatol 51 Q1 Loss Widens 51 Reiterates Sell 51 Q4 Loss Widens 51 Psychol 51 Rejects Takeover Bid 51 Guides Below 51 Biol 51 JPM WFS 51 Posts 4Q Profit 51 Bearish Moving Average 51 Begin Coverage 51 TEXT Moody cuts 51 Int'l Lease 51 suppl. 51 Teleconf 51 Profit Dips 51 ab #:# MESZ 51 #-# Full Text 51 BAML BARC 51 Earnings Climb 51 #:#-# [006] 51 Misses Q1 51 Downgrade Alert Watch 51 * vwd BUSINESS WIRE 51 Upgrade Alert 51 Dermatol 51 ps :# 51 Fitch Affirms Ratings 51 Outlook Disappoints 51 Shareholders Approve Merger 51 Q4 Profit Rises 51 Fourth Quarter Earnings Preview 51 J Pediatr 51 Raises FY# 51 Q2 Profit Plummets 51 FBR Capital Maintains 50 Clin Oncol 50 Shrs 50 Completes Purchase 50 1H Net Pft 50 #:#-#,# [003] 50 Enterp 50 Bearish Harami Pattern 50 4Q Profit Down 50 #:#-#,# CrossRef Medline [002] 50 H1 Profit Rises 50 Posts 4Q Loss 50 Upside Purchased 50 PRELIMINARY RATINGS ASSIGNED 50 N.V. 50 Maintains Sell 50 4Q Profit Jumps 50 Commun 50 INDICATED HIGHER 50 #:#-#,# CrossRef Medline [001] 50 overname 50 Posts 2Q 50 Reiterates FY# 50 Shareholders Approve Sale 50 Buys Stake 50 Announces Redemption 50 Regulator OKs 50 Completes Transaction 50 Pediatr 50 Proc Am 50 Appointed Depositary Bank 50 Earnings Scorecard 50 Ironhorse Tracker Radio 50 BAS DBS 50 J Am Acad 50 ChemPort 50 Reports 2Q Profit 50 VP Exercises Options 50 Declares Quarterly Cash Dividend 50 Boosts Stake 50 ValuEngine Upgrades 50 Pl. 50 Rating Reiterated 50 Q3 Profit Declines 50 Toxicol 50 Reports Narrower Loss 50 Restates Earnings 50 Options Trader Alert 50 Schaeffer Sentiment Snapshot 50 Successfully Completes Acquisition 50 Raises Dividend 50 Candlesticks Bearish Engulfing 50 Posts Higher 50 Baa1/BBB + 50 Joins OTCQX 50 Boosts Dividend 50 meldt 50 Diagn 50 4Q Loss 50 Nat Rev 50 Technol 50 CORRECTED CORRECTED 50 Q4 adj 50 #:#-# [001] 50 Q1 Profit Drops 50 Activity Alert 50 Sets Quarterly Dividend 50 Plans Job Cuts 50 Announce Joint Venture 50 Files Amended 50 Prs J 50 Profit Plunges 50 3Q Earnings 50 Delivers Strong 50 J Neurol 50 3Q Loss 50 ASM INTERNATIONAL 50 Beats Consensus 50 1Q Profit Rises 50 Posts Narrower Loss 50 BARC GS 50 4Q Net MYR#.#M [002] 50 Declares Qtr 50 Suppl. 50 Dordrecht Netherlands 50 3Q Profit Drops 50 RESEARCH ALERT Jefferies 50 Nat Clin Pract 50 Q3 Profit Jumps 50 Psychiatric Services #:#-#,# 50 4Q Profit Falls 50 Bullish Engulfing Formed 50 Q3 Profit Climbs 50 Selects Lucent Technologies 50 BRIBIE ISLAND 50 Backs FY# Earnings 50 Posts Steep 50 Lifts FY# View 50 Sinks Lower 50 Attracting Bullish Investors 50 Analysts Initiate Coverage 50 Bullish Speculation 50 Provides Status 50 Ups Guidance 50 Hematol 50 CFO Exercises Options 50 Reaffirms FY# Guidance 50 3Q Profit Rises 50 Post Earnings Checkup 50 Crit Care Med 50 FY# Q4 50 Glbl 50 Files Preliminary Prospectus 50 Extends Tender Offer 50 3Q Profit Falls 50 Annu Rev 50 Subsidiary Acquires 50 Interesting Options Volume 50 Sports Exerc 49 Shares Slump 49 Stockholders Approve Merger 49 Q4 Profit Declines 49 Misses Estimate 49 Trend Continues Down 49 Boosts Quarterly Dividend 49 Invs 49 Q1 oper profit 49 Article PubMed 49 Brain Res 49 Lowers Guidance 49 Article PubMed ChemPort 49 EMRG 49 App'x 49 Bearish Pressure Building 49 4Q Profit Rises 49 bln Sfr 49 Misses Expectations 49 Phys Ther 49 ABN AMRO Banco Bilbao 49 Ratings Definitions Research 49 Puls Biznesu pp. 49 Assumes Coverage 49 SVP Exercises Options 49 RESEARCH ALERT Credit Suisse 49 Backs FY# Guidance 49 Ups Dividend 49 Director Exercises Options 49 UBS Maintains Neutral 49 3Q Profit 49 Buys Into 49 1st Quarter Results 49 Proc Am Soc 49 1Q Profit Falls 49 H1 NET PROFIT 49 rtgs 49 Opp'n 49 Movers Roundup 49 Asset Mgmt 49 derde 49 Int'l Paper 49 Stock Upgraded 49 spud #-#-# drlg [003] 49 #:#-# [020] 49 Sees Slower 49 Posts 1Q Profit 49 Guides Inline 49 Star Stocks Poised 49 Inc. FY# Q3 49 Approaching Resistance 49 é o 49 Posts 3Q Profit 49 Seite 49 und sowie 49 Procures 49 Fitch Issues Presale 49 Recap HOU 49 Obstet Gynecol 49 Norway c.bank allots 49 TEXT Moody affirms 49 Completes Merger 49 Enters Into Merger Agreement 49 Corp. FY# Q3 49 Settles Dispute 49 Joint Surg Am 49 Net Profit Drops 49 Further Strengthens 49 BAS LEH 49 3Q Net Pft 49 MS Dhoni capt wk 49 4Q Profit Surges 49 C. ROLLE 49 strs 49 UBS Maintains Buy 49 Boosts Outlook 49 Completes Refinancing 49 Declares Dividend Increase 49 GuruFocus rated 49 Otolaryngol Head Neck Surg 49 Physiol 49 J Clin Psychiatry 49 Movers roundup 49 2Q Earnings 49 AD.L Top 49 Raytheon Rockwell Collins 49 Shareholders Elect 49 Announce Early Termination 49 1Q Profit Down 49 #:#-# [037] 49 Cumb 49 Takes Stake 49 2Q Profit Down 49 WOMEN 'S SEEDED LOSERS 49 Def. s 49 Jv 49 Boosts FY# 49 Clin 49 Mol Biol 49 Q1 Profit Dips 49 Am J Respir 49 Strk Div 1 49 Bullish Technical Alert 49 Sells Shares 49 Surg 49 Updates FY# EPS 49 Skype Telecom Italia 49 Sanofi Aventis Schering Plough 49 Hikes Dividend 48 JPM SSB 48 Increases Quarterly Dividend 48 #:#-# [019] 48 Backs FY# View 48 Completes Reorganization 48 Amends Credit 48 2Q Profit Jumps 48 #:#-# [007] 48 Shows Weakness 48 Microbiol 48 Third Quarter Profit Rises 48 Recap BAL 48 #:#-#,# CrossRef 48 Shareholders Approve 48 Extends Relationship 48 Increases Cash Dividend 48 UPDATE1 48 4th Qtr Profit 48 vE 48 1Q Loss 48 2Q Profit 48 Complimentary Analyst Research 48 PriceWatch Alert Technicals Showing 48 Traders Hedging Bets 48 pct beats f'cast 48 Hldrs 48 Nutr 48 d SPLC 48 Natural Res 48 Mgt 48 2Q Profit Up 48 Mulls Bid 48 Profit Jumps 48 2Q Pft 48 EUROPE ASIA EEU EMRG 48 Br J Psychiatry 48 Tops Estimate 48 lanceert 48 Hldgs 48 Posts Loss 48 BAML DB 48 Commences Cash 48 Lifts FY# Forecast 48 www.bharatbook.com 48 Considers Sale 48 REFILE UPDATE 1 48 Q3 Profit 48 Profit Triples 48 PMID # [002] 48 Zacks Analyst Interview 48 Psychiatry #:#-# [002] 48 Seen Posting 48 Mtge 48 CFO Resigns 48 Brief Excerpt RESEARCH 48 Liquidates 48 Buyers Accumulating Shares 48 Neurobiol 48 Nephrol 48 Ratings Unaffected 48 Posts 2Q Profit 48 Increases Quick Facts 48 Jointly Offer 48 Ratings Definitions 48 Welcomes Analyst 48 Adr 48 Pct Stake 48 Résultats 48 Options Activity 48 Begins Tender Offer 48 Fitch Expects 48 Epidemiol 48 Fourth Quarter Profit Drops 48 Significantly Expands 48 1Q Profit Slides 48 Posts Profit 48 #/#/# PriceWatch Alert Technicals [001] 48 #:#-# [023] 48 CORRECTED OFFICIAL 48 Endures Analyst Downgrade 48 Lowers Outlook 48 Finalize Agreement 48 Profit Sinks 48 EMBO J. 48 maakt 48 Profits Plunge 48 1Q Earnings 48 Urol 48 IG HCR ;) CO 48 MEN 'S SEEDED WINNERS 48 Indust 48 Shares Soar 48 1Q Profit Drops 48 Tops Views 48 yr frn A1 48 Intl Hldgs 48 Clin J 48 Slashes Dividend 48 IIROC Resume 48 Posts 1Q 48 3Q Profit Climbs 48 Biotechnol 48 Nears Deal 48 Biol Sci Med 48 2Q Profit Falls 48 Finalises 48 #.#/#.#m CL equals 48 Billion Update6 48 1Q Profit Climbs 48 Acquirer Company 48 1st Qtr Profit Rises 48 1Q Profit Soars 48 #:#-# [025] 48 Settle Fraud 48 Pretax Pft 48 3Q Profit Down 48 Successfully Delivers 48 Sign Definitive Agreement 48 Rpt 48 Ann Rheum Dis 48 Extends Commitment 48 Announces Organizational Changes 48 Sentiment Snapshot 48 pp. #-# [006] 48 Unch 48 PRESS RELEASE Fitch Rates 48 w NWI 48 #.#S [003] 48 Posts Third Quarter 48 #/#-# [009] 47 F.Supp 47 Fraud Suit Against 47 TABLE #.OS 47 Shares Creeping Higher 47 4Q Profit Soars 47 % HIGHER 47 HIGH GRADE BOND SALES 47 Indx 47 neemt 47 Selects Teradata 47 1Q Profit 47 Initiated Coverage Alert 47 Ramps Up Production 47 Raises Quarterly Dividend 47 FY Net Pft 47 PRESS RELEASE Fitch Affirms 47 Peru Movicom 47 RPT UPDATE 1 47 INDICATED LOWER 47 1Q Profit Declines 47 Strategies Advises 47 CEO Discusses Q1 47 Eqty 47 Resp't 47 Completes Spin Off 47 Sgle Strk 47 Provides Preliminary 47 #/#/# PriceWatch Alert Technicals [003] 47 -WILL HEAD 47 3Q Profit Surges 47 Mulls Sale 47 #-# Abstract Full [001] 47 Announces Refinancing 47 Reminds Shareholders 47 Men Prs 47 Int J Epidemiol 47 Suspends Dividend 47 Stk 47 Stks 47 Svc 47 Shares Climb 47 IG IGS ;) CO 47 Sweetens Offer 47 Recap NYM 47 Lupatech BMF & 47 3rd Quarter Results 47 4Q Profit Drops 47 Insightful Updates 47 Constr 47 ISOCOUNTRY3 47 Prs WoW 47 For Undisclosed Sum 47 Profit Slips 47 #-# Abstract Full [002] 47 Ppty 47 2nd Qtr Profit Rises 47 suppl 47 Mil. 47 Hypertens 47 Arch Facial Plast 47 Boosts Profit 47 Earnings Soar 47 Posts Narrower 4Q Loss 47 Mol Cell 47 J Neurosurg 47 PTI LKJ 47 1Q Profit Jumps 47 Misses Forecasts 47 Makes Unsolicited Bid 47 Pl. s 47 vs. Exp 47 Jointly Develop 47 PRESS RELEASE Fitch Downgrades 47 Withdraws Ratings 47 Revises Earnings 47 Mkt Cap 47 MORNING PREP MORNING PREP 47 Enters Into Definitive Agreement 47 Shares Plummet 47 2d ed 47 Executive Exercises Options 47 Drags Down 47 1Q Net Pft 47 AG Germanyâ 47 ALGESTER 47 border="0"> 47 4Q Profit 47 Shrs Up 47 YEN EJ 47 Profits Rise 47 plc Director PDMR 47 J Am Coll 47 Profit Doubles 47 Rehabil 47 Provides Shareholder 47 Shareholders Approve Takeover 47 Def. 47 Unveils Breakthrough 47 EARNINGS PREVIEW 47 mdec #-# 47 Pac Lf 47 #/#/# PriceWatch Alert Technicals [002] 47 Acquire Controlling Interest 47 Biol Phys 47 +5 bp 47 Profit Misses Estimates 47 Am J Epidemiol 47 cwmni 47 Stocks Decline Paced 47 J Child Adolesc 47 3Q Profits 47 Profit Beats Expectations 47 dpa ds 47 forf 47 4Q Earnings 47 Execs Sentenced 47 F. Supp 47 Thromb Haemost 47 Half Profit Rises 47 RU EUROPE EEU EMRG 47 Q2 Profit 47 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 47 Cl TSX 47 Samsung Sendo 47 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 47 AM Best Assigns 47 SFR SingTel T 47 Says 3Q Profit 47 AUS bt 47 Posts Smaller 47 3rd Qtr Profit 47 Pr TSX 47 Reduces Workforce 47 #:#-# [022] 47 Outperform Analyst Blog 47 Profit Climbs 47 Announce Receipt 47 Sees Robust 47 Challenges Await 47 から 47 Gets Nod 46 Exercises Warrants 46 Shares Surge 46 Shareholders Reject 46 -#.# -#.# -#.# [006] 46 Fd Inc 46 Stifel Nicolaus downgrades 46 Corporati 46 FOUL FOUL #.#m 46 1hour #mins #.#secs M 46 azioni 46 Brief Scores 46 Narrows Loss 46 Cardiol 46 settembre 46 Milliarden 46 #U [005] 46 Med Assoc 46 J Med 46 Profit Declines 46 Increase Stake 46 ExxonMobil Fluor 46 Q1 opg 46 AUTOMATIC WITH OVERDRIVE FUEL 46 Quarterly Profit Rises 46 Emerg Med 46 Reduces Stake 46 Johnson Controls Lear 46 maailman 46 Posts 3Q 46 eigen aandelen 46 Yet Misses Estimate 46 Reaffirms Earnings 46 Cancer Res 46 More Than Quadruples 46 Lowers Earnings 46 Grn 46 Arch Neurol 46 1st Qtr Net 46 JOSH IS 46 Beats Forecast 46 Health Aff Millwood 46 Eur Respir J 46 Reprod 46 o dan 46 FY# Q2 46 Grp 46 Declares Quarterly Dividends 46 o swyddi 46 Declares Quarterly Preferred Stock 46 HOT STOCKS 46 Cir 46 Miner Res 46 LSE EVR 46 NTPC Wipro 46 Prs G 46 J Biol Chem 46 Cell Mol Biol 46 Glance STOCKS NEWS EUROPE 46 Neutral Analyst Blog 46 Announces Expiration 46 J Am Soc 46 Announce Reseller Agreement 46 BLN EUROS 46 Extend Partnership 46 IIROC Halt 46 Trading Halt 46 See Tex. 46 Upside Looming 46 Ltd SGM 46 rhaid i 46 två 46 Presse économique 46 Corporation Declares Preferred 46 % #gt 46 Insur 46 Conv 46 o hyd 46 Considers Bid 46 Cell Biol 46 General Psychiatry #:#-#,# 46 2Q Loss 46 #:#-# [014] 46 Behav 46 MFC Global Invest 46 J Pathol 46 Acquire Stake 46 3Q Profit Plunges

Back to home page